| [1] |
Liyanage I, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review [J]. Lancet，2015，385(9981):1975-1982.
|
| [2] |
Zhang L，Wang F，Wang L，et al.Prevalence of chronic kidney disease in China：a cross-sectional survey [J]. Lancet，2012，379(9818):815-822.
|
| [3] |
张路霞，王芳，王莉，等．中国慢性肾脏病患病率的横断面调查[J]．中华内科杂志，2012，51(7):570.
|
| [4] |
Zhang L，Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing [J]. Am J Kidney Dis，2008，51(3):373-384.
|
| [5] |
Chen W, Chen W, Wang H, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China [J]. Nephrol Dial Transplant，2008，24(4):1205-1212.
|
| [6] |
Chen N, Wang W, Huang Y, et al. Community-based study on CKD subjects and the associated risk factors [J]. Nephrol Dial Transplant，2009，24(7):2117-2123.
|
| [7] |
Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030 [J]. Int J Obes (Lond)，2008，32(9):1431-1437.
|
| [8] |
Hallan SI, Øvrehus MA, Romundstad S, et al. Long-term trends in the prevalence of chronic kidney disease and the influence of cardiovascular risk factors in Norway [J]. Kidney Int，2016，90(3):665-673.
|
| [9] |
Cao H. Adipocytokines in obesity and metabolic disease [J]. J Endocrinol, 2014，220(2):T47-T59.
|
| [10] |
Weisinger JR, Kmpson RL, Eldridge FL，et al. The nephritic syndrome：a complication of massive obesity [J]. Ann Inern Med，1974，81:440.
|
| [11] |
陈慧梅，刘志红，李世军，等．肥胖相关性肾病患者流行病学资料及临床病理特征分析[J]．肾脏病与透析肾移植杂志，2008，17(1):30-37.
|
| [12] |
沈雯雯，刘志红，陈慧梅，等. 肥胖相关性肾病：体重指数与蛋白尿的关系[J]. 肾脏病与透析肾移植杂志，2009，18(6):504-512.
|
| [13] |
王霞，宗慧敏，刘春蓓，等．肥胖相关性肾病的远期预后及危险因素分析[J]．肾脏病与透析肾移植杂志，2018，27(6):507-512.
|
| [14] |
Chen H，Liu Z，Zeng C, et al. Podocyte lesions in patients with obesity-related glomerulopathy [J]．Am J Kidney Dis，2006，48(5):772-779.
|
| [15] |
Kambham N，Markowitz GS，Valeri AM，et al. Obesity-related glomerulopathy：an emerging epidemic [J]. Kidney Int，2001，59(4):1498-1509.
|
| [16] |
Praga M，Hemández E，Morales E，et al. Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis [J]. Nephrol Dial Transplant，2001，16(9):1790-1798.
|
| [17] |
刘纪实，陈志恒，李维，等.26655例体检人群中肥胖指数与慢性肾脏病联系的横断面调查[J]．中南大学学报(医学版)，2016，41(5):446-454.
|
| [18] |
Kramer H, Luke A, Bidani A, et al. Obesity and prevalent and incident CKD: The hypertension detection and follow-up program [J]．Am J Kidney Dis，2005，46(4):587-594.
|
| [19] |
Evans PD, Mclntyre NJ, Fluck RJ, et al. Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3 [J]. PLoS One，2012, 7(4):e34699.
|
| [20] |
Takehiko T, Toshimi, Hiroyasu I, et al. The dose-response relationship between body mass index and the risk of incident stage ≥3 chronic kidney disease in a general Japanese population: the Ibaraki prefectural health study (IPHS) [J]. J Epidemiol，2014，24(6):444-451.
|
| [21] |
Hsu CY，Iribarren C，McCulloch CE，et al.Risk factors for end-stage renal disease：25-year follow-up [J]. Arch Intern Med，2009，169(4):342-350.
|
| [22] |
Navaneethan SD, Schold JD, Kirwan JP, et al. Metabolic syndrome, ESRD, and death in CKD [J]. Clin J Am Soc Nephrol，2013，8(6):945-952.
|
| [23] |
丁奕，田娜，周晓玲，等．肥胖与IgA肾病患者独立肾脏危险因子的相关性分析[J]．中华肾脏病杂志，2017，33(5):321-326.
|
| [24] |
Sowers JR. Metabolic risk factors and renal disease [J]. Kidney Int，2007，71(8):719-720.
|
| [25] |
Hashimoto Y, Tanaka M, Okada H, et al. Metabolically healthy obesity and risk of Incident CKD [J]. Clin J Am Soc Nephrol，2015, 10(4):578-583.
|
| [26] |
Panwar B, Hanks LJ, Tanner RM, et al. Obesity, metabolic health, and the risk of end-stage renal disease [J]. Kidney Int，2015，87(6):1216-1222.
|
| [27] |
Francois B, Christophe M, Nicolas M. Overweight/obesity revisited as a predictive risk factor in primary IgA nephropathy [J]. Nephrol Dial Transplant，2013，28(Suppl 4):160-166.
|
| [28] |
Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population [J]. J Am Soc Nephrol，2006，17(5):1453-1459.
|
| [29] |
Johansen KL, Young B, Kaysen GA, et al. Association of body size with outcomes among patients beginning dialysis [J]. Am J Clin Nutr，2004，80(2):324-332.
|
| [30] |
Kalantar-Zadeh K, Kamrampour N, Kopple JD, et al. Association between novel HDL inflammatory/properties with body mass index in hemodialysis patients [J]. J Am Soc Nephrol，2004，15:172A.
|
| [31] |
Chazot C, Gassia JP, Di Benedetto A, et al. Is there any survival advantage of obesity in Southern European haemodialysis patients? [J]. Nephrol Dial Transplant，2009，24(9):2871-2876.
|
| [32] |
Li T, Liu J, An S, et al. Body mass index and mortality in patients on maintenance hemodialysis: a meta-analysis [J]．Int Urol Nephrol，2014，46(3):623-631.
|
| [33] |
Kalaitzidis RG, Siamopoulos KC. The role of obesity in kidney disease: recent findings and potential mechanisms [J]. Int Urol Nephrol，2011，43(3):771-784.
|
| [34] |
Fouque D, Kalantar-Zadeh K, Kopple J，et al.A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease [J]. Kidney Int，2008，73(4):391-398.
|
| [35] |
Abbott KC, Glanton CW, Trespalacios FC, et al. Body mass index, dialysis modality, and survival: analysis of the of the United States Renal Data System Dialysis Morbidity and Mortality Wave II Study [J]. Kidney Int，2004，65(2):597-605.
|
| [36] |
Kiran VR, Zhu TY, Yip T, et al. Body mass index and mortality risk in Asian peritoneal dialysis patients in Hong Kong-impact of diabetes and cardiovascular disease status [J]. Perit Dial Int，2014，34(4):390-398.
|
| [37] |
王奕齐，华林，江薇，等．腹膜透析患者体质量指数与预后的相关关系[J]．中华肾脏病杂志，2014，30(10):744-750.
|
| [38] |
Blake PG.Targets in CAPD and APD prescription [J]．Perit Dial Int，1996, 16 (Suppl 1):S143-S146.
|
| [39] |
Jensen RA, Nolph KD, Moore HL, et al.Weight limitations for adequate therapy using commonly performed CAPD and NIPD regimens [J]. Semin Dial，1994，7(1):61-64.
|
| [40] |
Beddhu S, Pappas LM, Ramkumar N, et al. Effects of body size and body composition on survival in hemodialysis patients [J]. J Am Soc Nephrol，2003，14(9):2366-2372.
|
| [41] |
Ramkumar N, Pappas LM, Beddhu S. Effect of body size and body composition on survival in peritoneal dialysis patients [J]. Perit Dial Int，2005，25(5):461-469.
|
| [42] |
Honda H, Qureshi AR, Axelsson J, et al. Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality [J]. Am J Clin Nutr，2007，86(3):633-638.
|
| [43] |
Kalantar-Zadeh K, Streja E, Kovesdy CP, et al. The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis [J]. Mayo Clin Proc，2010，85(11):991-1001.
|
| [44] |
王家林，张敏，王少艳．维持性血液透析患者瘦体质量与死亡风险相关性研究[J]．中国血液净化，2019，18(6):382-385.
|
| [45] |
Grosso G, Corona D, Mistretta A, et al. The role of obesity in kidney transplantation outcome [J]. Transplant Proc，2012，44(7):1864-1868.
|
| [46] |
Molnar MZ, Kovesdy CP, Mucsi I, et al. Higher recipient body mass index is associated with post-transplant delayed kidney graft function [J]. Kidney Int，2011，80(2):218-224.
|
| [47] |
Hatamizadeh P, Molnar MZ, Streja E, et al. Recipient-related predictors of kidney transplantation outcomes in the elderly [J]. Clin Transplant，2013，27(3):436-443.
|